Demand has broadened across independent fronts: growth is now coming from several distinct, currently-producing sources
The model's full reasoning — Q2 2021 call → NOWe need answer YES or NO based on transcript. Need determine if management describes current growth carried by several distinct independent sources at same time, at least three genuinely different engines, each already producing real current business, and breadth is recent/building, with several sources still have most contribution ahead. Need use only transcript. Let's parse. Organon has three franchises: women's health, biosimilars, established brands. But question asks current growth carried by several distinct engines. Management discusses growth in Q2: women's health grew 16% ex-FX, biosimilars grew 35% ex-FX, established brands down 10% ex-FX. So growth is from women's health and biosimilars, not established brands. Within women's health: Nexplanon up 39%, fertility FOLLISTIM up 40%, fertility portfolio strength. Biosimilars: RENFLEXIS up 38%, Ontruzant up 13%, Hadlima launched in Australia/Canada performing well. Also China growth, retail channel. But are these distinct independent engines? Need at least three genuinely different engines each already producing real current business. Management mentions: Nexplanon (contraception), fertility (different product/customer), biosimilars (different therapeutic area). Also China retail channel? But need management conveys breadth is recent/building, company was until recently narrower, growth carried by fewer engines, several sources still have most contribution ahead. Does management say that? They say "we are very early in our journey", "building something special", "early progress demonstrates commitment". They mention "we have begun to execute on vision" with acquisitions. But for current growth, they describe women's health and biosimilars as growth engines. Established brands is cash flow. They say "all three franchises are delivering on their objectives". But growth is mainly women's health and biosimilars. Are there at least three distinct engines? Let's examine. Slide 6: NEXPLANON blockbuster potential, LARC market. Fertility portfolio strength. Biosimilars. Also China? They mention China as geographic region with positive momentum, retail channel growth. But is that a distinct engine? They say "In China, we had several positive areas of momentum that more than offset impact from VBP... respiratory market recovering... fertility portfolio outpaced market...
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| E | Eni S.p.A. | Q1 2024 | 2024-04-24 | B+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PSFE | Paysafe Limited | Q4 2023 | 2024-03-07 | C+ |
| FRPH | FRP Holdings, Inc. | Q4 2023 | 2024-03-07 | C+ |
| GTLB | GitLab Inc. | Q4 2024 | 2024-03-04 | C+ |
| INTR | Inter & Co, Inc. | Q4 2023 | 2024-02-08 | B+ |
| TBLA | Taboola.com Ltd. | Q3 2023 | 2023-11-08 | B+ |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| ANGO | AngioDynamics, Inc. | Q1 2024 | 2023-10-04 | B |
| CTLP | Cantaloupe, Inc. | Q4 2023 | 2023-09-06 | B+ |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| ZOM | Zomedica Corp. | Q2 2023 | 2023-08-10 | C |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| INTT | inTEST Corporation | Q2 2023 | 2023-08-04 | A |
| FOUR | Shift4 Payments, Inc. | Q2 2023 | 2023-08-03 | B+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| PERI | Perion Network Ltd. | Q2 2023 | 2023-08-02 | A |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| EDU | New Oriental Education & Technology Grou | Q3 2023 | 2023-04-19 | B |
| ISRG | Intuitive Surgical, Inc. | Q4 2022 | 2023-01-24 | C |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| GDRX | GoodRx Holdings, Inc. | Q2 2022 | 2022-08-08 | F |
| XHR | Xenia Hotels & Resorts, Inc. | Q2 2022 | 2022-08-05 | A |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| UGRO | urban-gro, Inc. | Q1 2022 | 2022-05-13 | D |
| XMTR | Xometry, Inc. | Q1 2022 | 2022-05-11 | B+ |
| CLAR | Clarus Corporation | Q1 2022 | 2022-05-09 | B |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| ABNB | Airbnb, Inc. | Q1 2022 | 2022-05-03 | B+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| WSC | WillScot Mobile Mini Holdings Corp. | Q4 2021 | 2022-02-25 | B+ |
| LMND | Lemonade, Inc. | Q4 2021 | 2022-02-24 | D |
| SNOW | Snowflake Inc. | Q3 2022 | 2021-12-01 | A |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| ZH | Zhihu Inc. | Q3 2021 | 2021-11-22 | D |
| BRAG | Bragg Gaming Group Inc. | Q3 2021 | 2021-11-08 | B+ |
| ENV | Envestnet, Inc. | Q3 2021 | 2021-11-08 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| SXC | SunCoke Energy, Inc. | Q3 2021 | 2021-11-01 | A |
| FFWM | First Foundation Inc. | Q3 2021 | 2021-10-26 | B |
| CROX | Crocs, Inc. | Q3 2021 | 2021-10-21 | B+ |
| DG | Dollar General Corporation | Q2 2021 | 2021-08-26 | A |
| ZIM | ZIM Integrated Shipping Services Ltd. | Q2 2021 | 2021-08-18 | B+ |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| Z | Zillow Group, Inc. | Q2 2021 | 2021-08-05 | B |
| NOV | NOV Inc. | Q2 2021 | 2021-07-28 | C+ |
| STRA | Strategic Education, Inc. | Q2 2021 | 2021-07-28 | C |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| AMGN | Amgen Inc. | Q3 2018 | 2018-10-30 | B+ |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| BCO | The Brink's Company | Q3 2018 | 2018-10-24 | C |
| NDLS | Noodles & Company | Q3 2018 | 2018-10-23 | B+ |
| AUDC | AudioCodes Ltd. | Q3 2018 | 2018-10-23 | A |
| YEXT | Yext, Inc. | Q2 2019 | 2018-08-30 | C+ |
| TNC | Tennant Company | Q2 2018 | 2018-07-25 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| MXL | MaxLinear, Inc. | Q2 2017 | 2017-08-08 | C+ |
| ST | Sensata Technologies Holding plc | Q2 2017 | 2017-07-25 | B+ |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| HUBB | Hubbell Incorporated | Q2 2017 | 2017-07-25 | B+ |
| CNS | Cohen & Steers, Inc. | Q2 2017 | 2017-07-20 | B |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
| PPSI | Pioneer Power Solutions, Inc. | Q4 2016 | 2017-03-10 | B |
| ABR | Arbor Realty Trust, Inc. | Q4 2016 | 2017-03-03 | B+ |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| LGND | Ligand Pharmaceuticals Incorporated | Q4 2016 | 2017-02-23 | C+ |
| PYPL | PayPal Holdings, Inc. | Q4 2016 | 2017-01-26 | B+ |
| PNFP | Pinnacle Financial Partners, Inc. | Q2 2016 | 2016-07-20 | B |
| BX | Blackstone Inc. | Q1 2016 | 2016-04-21 | B |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
GDRX · Q2 2022 → YESThe question is about whether management describes the company's CURRENT growth as being carried by SEVERAL DISTINCT, INDEPENDENT SOURCES AT THE SAME TIME — at least three genuinely different engines,...YES The transcript shows management describing current growth as carried by multiple distinct engines: prescription transactions (still the core but with recent challenges), subscriptions revenue (82% YoY growth), and Pharma Manufacturer Solutions (more than doubled YoY). They explicitly frame the diversification as a recent development, noting that other offerings now make up 30% of revenue compared to 5% just three years ago, with several sources like subscriptions and pharma still having most of their contribution ahead due to significant TAM and low penetration. This breadth is presented as newly meaningful for the company, reflecting the early stage of these newer fronts rather than a long-standing diversified business.
TOUR · Q4 2017 → YESThe question is about whether management describes current growth being carried by several distinct, independent sources at the same time — at least three genuinely different engines — each already pr...YES Management describes current growth as carried by multiple distinct, independent engines that are already producing real revenue and activity: packaged tours (organized and self-guided), financial services and commissions, offline retail stores (18% of GMV in Q4 2017, launched 2016), direct procurement (40% of GM 2017), and corporate TMC services (more than 200% YoY growth). They explicitly note diversification of sales channels (online, mobile, loyalty, offline, B2B/corporate) and that the company was narrower until recently, with offline retail and corporate TMC expanding in 2016–2017 while local operators remain small but growing.
CYBR · Q3 2021 → YESThe question is about whether management describes current growth being carried by several distinct, independent sources at the same time — at least three genuinely different engines — each producing ...YES The transcript shows management describing current growth as driven by multiple distinct, independent engines operating simultaneously: record SaaS bookings and subscription ARR growth (131%), the Identity Security platform centered on Privileged Access Management (PAM) and Privilege Cloud with new logos over 230, EPM with another record quarter, Access and DevSecOps offerings, plus expansion across geographies (every region growing) and verticals (new logos in law firms, software, oil & gas, retailers, government). These are presented as real, current business with concrete metrics and customer examples, not plans.